Mechanistic Pathways of Mindfulness Meditation in Post-traumatic Stress Disorder.



Status:Completed
Conditions:Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:25 - 65
Updated:4/21/2016
Start Date:January 2009
End Date:May 2014

Use our guide to learn which trials are right for you!

The purpose of this study is to find out how meditation influences certain systems in the
body: nervous system, hormonal system, and respiratory system. Another purpose is to see how
meditation may help improve post-traumatic stress disorder symptoms.

This study requires nine visits to the clinic: one screening visit, one baseline visit, six
training sessions, and one endpoint visit. There will be approximately 100 people enrolled
in this study who will be randomly allocated to one of four groups: a slow breathing group,
a meditation group, a meditation plus slow breathing group and a sitting quietly group.

Participants will undergo a telephone screening, a screening visit, baseline visit, six
intervention visits (once per week for six weeks), and one endpoint visit (one week after
the final training visit). A telephone screening and screening visit will ensure participant
eligibility. The screening visit included structured clinician interviews on PTSD symptoms
and other mental health disorders, completion of questionnaires, and receipt of home saliva
collection kit. At the baseline visit, electrodes will be attached to measure the electrical
activity of head, chest, skin, and respiration and blood pressure during a computer task.
Intervention visits include slow breathing, meditation, mediation and slow breathing, or
sitting quietly depending on which group the participant is allocated to. Breathing rates
and other electrical activity of the body will be measured also. Breathing rate will be
measured with an elastic band that is placed around the chest. Electrical activity will be
measured by the electrodes that will be placed on the scalp, chest and skin. The endpoint
visit will be exactly the same as the baseline visit.

Inclusion Criteria:

- Combat veteran (defined by a score of ≥7 on the Combat exposure scale)

- Chronic PTSD diagnosis

- Age range (25-65 years)

- Both genders

- Good general medical health

- Stable dose of medications for concurrent stable medical conditions for at least 4
weeks prior to start of the study.

- Willing and able to provide informed consent.

Exclusion Criteria:

Significant chronic medical illness including:

- current cancer treatment,

- unstable angina,

- recent myocardial infarction,

- current or past history of stroke,

- transient ischemic attack,

- congestive heart failure,

- chronic renal or hepatic failure,

- hypothyroidism

Psychiatric or behavioral illness including:

- schizophrenia,

- schizoaffective disorder,

- bipolar disorder,

- psychotic disorder (not including transient dissociative states or flashbacks
associated with PTSD re-experiencing symptoms),

- any DSM-IV cognitive disorder,

- current delirium,

- psychiatric instability or situational life crises, including evidence of being
actively suicidal or homicidal, or any behavior which poses an immediate danger to
the patient or others.

- Substance dependence disorder within 3 months of the study or

- current substance use other than alcohol (no more than 2 drinks/day by self-report)

- Sexual assault as primary PTSD event/s.

- Planning to move from the area in the next year.

- Prior or current meditation practice.
We found this trial at
1
site
3181 Southwest Sam Jackson Park Road
Portland, Oregon 97239
503 494-8311
Oregon Health and Science University In 1887, the inaugural class of the University of Oregon...
?
mi
from
Portland, OR
Click here to add this to my saved trials